Dexmedetomidine inhibits muscarinic type 3 receptors expressed in Xenopus oocytes and muscarine-induced intracellular Ca2+ elevation in cultured rat dorsal root ganglia cells
- PMID: 17563882
- DOI: 10.1007/s00210-007-0168-4
Dexmedetomidine inhibits muscarinic type 3 receptors expressed in Xenopus oocytes and muscarine-induced intracellular Ca2+ elevation in cultured rat dorsal root ganglia cells
Abstract
Dexmedetomidine, an alpha(2)-adrenoceptor agonist, has been approved for clinical use, although the mechanism of dexmedetomidine action has not been fully elucidated. Several studies have shown that G protein-coupled receptors (GPCRs) are recognized as targets for anesthetics and analgesics. Therefore, it is of interest to determine whether dexmedetomidine affects the function of GPCRs other than the alpha(2)-adrenoceptor. We examined the effects of dexmedetomidine on M(1), M(3), 5-HT(2C), substance P, and orexin 1 receptors in Xenopus oocytes expressing individual receptors. In addition, we investigated the effects of dexmedetomidine on muscarinic receptor-mediated changes in [Ca(2+)](i) in the dorsal root ganglia (DRG) of 3-week-old Wister rats. Dexmedetomidine did not affect the 5-HT(2C)-, or substance P-induced Cl(-) currents and had little inhibition on the orexin A-induced current in oocytes expressing the respective receptors. The compound also had little effect on the acetylcholine (ACh, 1 microM)-induced Ca(2+)-activated Cl(-) currents in Xenopus oocytes expressing M(1) receptors. In contrast, dexmedetomidine inhibited the ACh-induced currents in Xenopus oocytes expressing M(3) receptors; 1 nM, 10 nM, 100 nM, and 1 microM dexmedetomidine reduced the current to 66.5 +/- 4.8, 51.3 +/- 12, 34.6 +/- 11, and 26.8 +/- 6.4% of the control value, respectively (EC(50) = 3.5 +/- 0.7 nM). Dexmedetomidine reduced the ACh-induced Cl(-) currents after treatment with the selective protein kinase C inhibitor GF109203X. Moreover, the compound inhibited the muscarinic receptor-mediated increases in [Ca(2+)](i) in cultured DRG cells in a concentration-dependent manner. Dexmedetomidine inhibits the function of M(3) receptors, in addition to its agonistic effects on alpha(2)-adrenoceptors, which provides further insight into the pharmacological properties of dexmedetomidine.
Similar articles
-
Analysis of the effects of halothane on Gi-coupled muscarinic M2 receptor signaling in Xenopus oocytes using a chimeric G alpha protein.Pharmacology. 2004 Nov;72(3):205-12. doi: 10.1159/000080106. Pharmacology. 2004. PMID: 15452370
-
The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptor-induced responses in Xenopus oocytes expressing M1 and M3 receptors.Naunyn Schmiedebergs Arch Pharmacol. 2005 Mar;371(3):221-8. doi: 10.1007/s00210-005-1022-1. Epub 2005 Mar 19. Naunyn Schmiedebergs Arch Pharmacol. 2005. PMID: 15900516
-
The effects of the tramadol metabolite O-desmethyl tramadol on muscarinic receptor-induced responses in Xenopus oocytes expressing cloned M1 or M3 receptors.Anesth Analg. 2005 Jul;101(1):180-6, table of contents. doi: 10.1213/01.ANE.0000154303.93909.A3. Anesth Analg. 2005. PMID: 15976229
-
The inhibitory effects of alphaxalone on M1 and M3 muscarinic receptors expressed in Xenopus oocytes.Anesth Analg. 2003 Aug;97(2):449-455. doi: 10.1213/01.ANE.0000068985.78588.E1. Anesth Analg. 2003. PMID: 12873933
-
Inhibition by tramadol of muscarinic receptor-induced responses in cultured adrenal medullary cells and in Xenopus laevis oocytes expressing cloned M1 receptors.J Pharmacol Exp Ther. 2001 Oct;299(1):255-60. J Pharmacol Exp Ther. 2001. PMID: 11561087
Cited by
-
Comparison of intravenous lidocaine and dexmedetomidine infusion for prevention of postoperative catheter-related bladder discomfort: a randomized controlled trial.BMC Anesthesiol. 2019 Mar 18;19(1):37. doi: 10.1186/s12871-019-0708-8. BMC Anesthesiol. 2019. PMID: 30885134 Free PMC article. Clinical Trial.
-
Comparison of Two Different Sedation Protocols during Transvaginal Oocyte Retrieval: Effects on Propofol Consumption and IVF Outcome: A Prospective Cohort Study.J Clin Med. 2021 Mar 1;10(5):963. doi: 10.3390/jcm10050963. J Clin Med. 2021. PMID: 33804575 Free PMC article.
-
Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.Drug Des Devel Ther. 2019 Sep 2;13:3137-3149. doi: 10.2147/DDDT.S219533. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31564830 Free PMC article.
-
Dexmedetomidine Protects Against Chemical Hypoxia-Induced Neurotoxicity in Differentiated PC12 Cells Via Inhibition of NADPH Oxidase 2-Mediated Oxidative Stress.Neurotox Res. 2019 Jan;35(1):139-149. doi: 10.1007/s12640-018-9938-7. Epub 2018 Aug 15. Neurotox Res. 2019. PMID: 30112693
-
Intraoperative administration of dexmedetomidine reduced the postoperative catheter-related bladder discomfort and pain in patients undergoing lumbar microdiscectomy.J Anesth. 2018 Feb;32(1):41-47. doi: 10.1007/s00540-017-2425-0. Epub 2017 Nov 2. J Anesth. 2018. PMID: 29098393 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous